Xsensio, a specialist in wearable sensing technology, has been selected to lead the €2.4M XPATCH consortium funded by the European program Eurostars. The startup and its four European partners develop the next-generation wearable skin patch for ultrasensitive real-time health and wellness monitoring. XPATCH will leverage Xsensio’s proprietary Lab-on-Skin wearable sensing platform.
Xsensio SA develops a proprietary Lab-on-Skin sensing platform for next-generation wearable devices that tracks biochemical information at the surface of the skin, providing unprecedented real-time information on health and wellness, in a simple and non-invasive way.
Together with its partners, including Fraunhofer IZM, OmegaLambdaTec GmbH, R-DAS, s. r. o. and the Vrije Universiteit Amsterdam (Stichting VU), Xsensio has won a Eurostars grant of for the XPATCH project.
The consortium will develop a breakthrough wearable product that will reveal and explore a new dimension of data in real-time, namely biochemical information in sweat. The project, which is based on several proprietary innovations, will leverage Xsensio’s proprietary Lab-on-Skin wearable sensing platform, a modular sensing tool capable of continuously detecting a wide range of biomarkers at the surface of our skin – e.g. electrolytes, hormones, proteins – using an infinitesimally small amount of biofluid.
In this project, the consortium will innovate on multiple fronts: it will expand the range of sensors, implement a flexible battery, heterogeneously integrate all components into a single microsystem on flexible substrate, test the product in a clinical environment and develop an application programming interface to provide valuable health data. This project will deliver a validated XPATCH, which is compatible with current wearables on the market.
Please login or sign up to comment.
Commenting guidelines